{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:16:32Z","timestamp":1776125792283,"version":"3.50.1"},"reference-count":35,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"abstract":"<jats:p>Familial tumoral calcinosis is characterized by ectopic calcifications and hyperphosphatemia. The disease is caused by inactivating mutations in fibroblast growth factor 23 (FGF23), Klotho (KL), and uridine diphosphate-N-acetyl-\u03b1-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3). In vitro studies indicate that GALNT3 O-glycosylates a phosphaturic hormone, FGF23, and prevents its proteolytic processing, thereby allowing secretion of intact FGF23. In this study we generated mice lacking the Galnt3 gene, which developed hyperphosphatemia without apparent calcifications. In response to hyperphosphatemia, Galnt3-deficient mice had markedly increased Fgf23 expression in bone. However, compared with wild-type and heterozygous littermates, homozygous mice had only about half of circulating intact Fgf23 levels and higher levels of C-terminal Fgf23 fragments in bone. Galnt3-deficient mice also exhibited an inappropriately normal 1,25-dihydroxyvitamin D level and decreased alkaline phosphatase activity. Furthermore, renal expression of sodium-phosphate cotransporters and Kl were elevated in Galnt3-deficient mice. Interestingly, there were sex-specific phenotypes; only Galnt3-deficient males showed growth retardation, infertility, and significantly increased bone mineral density. In summary, ablation of Galnt3 impaired secretion of intact Fgf23, leading to decreased circulating Fgf23 and hyperphosphatemia, despite increased Fgf23 expression. Our findings indicate that Galnt3-deficient mice have a biochemical phenotype of tumoral calcinosis and provide in vivo evidence that Galnt3 plays an essential role in proper secretion of Fgf23 in mice.<\/jats:p>","DOI":"10.1210\/en.2008-0877","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T01:45:47Z","timestamp":1234489547000},"page":"2543-2550","source":"Crossref","is-referenced-by-count":137,"title":["Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression"],"prefix":"10.1210","volume":"150","author":[{"given":"Shoji","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea H.","family":"Sorenson","sequence":"additional","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Austin","sequence":"additional","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald S.","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Fritz","sequence":"additional","affiliation":[{"name":"Section on Biological Chemistry (T.A.F.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Moh","sequence":"additional","affiliation":[{"name":"Departments of Microbiology and Immunology (A.M.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siu L.","family":"Hui","sequence":"additional","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[{"name":"Departments of Medicine (S.I., A.H.S., A.M.A., D.S.M., S.L.H., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"},{"name":"Departments of Medical and Molecular Genetics (M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"2020071614205734200_R1","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.","volume":"90","author":"Araya","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.","volume":"14","author":"Benet-Page\u0300s","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2020071614205734200_R3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","article-title":"A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification.","volume":"118","author":"Chefetz","year":"2005","journal-title":"Hum Genet"},{"key":"2020071614205734200_R4","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.","volume":"90","author":"Larsson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jcp.2005.026369","article-title":"Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family.","volume":"59","author":"Campagnoli","year":"2006","journal-title":"J Clin Pathol"},{"key":"2020071614205734200_R6","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","article-title":"A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.","volume":"90","author":"Ichikawa","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10038-006-0377-6","article-title":"Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred.","volume":"51","author":"Specktor","year":"2006","journal-title":"J Hum Genet"},{"key":"2020071614205734200_R8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"2020071614205734200_R9","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071614205734200_R10","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1681\/ASN.2005050573","article-title":"Fibroblast growth factor 23: roles in health and disease.","volume":"16","author":"Imel","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2020071614205734200_R11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.","volume":"22","author":"Frishberg","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2020071614205734200_R12","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071614205734200_R13","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","article-title":"Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.","volume":"146","author":"Larsson","year":"2005","journal-title":"Endocrinology"},{"key":"2020071614205734200_R14","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho.","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071614205734200_R15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23.","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"2020071614205734200_R16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing.","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"2020071614205734200_R17","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1210\/me.2003-0048","article-title":"Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system.","volume":"17","author":"Tsujikawa","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2020071614205734200_R18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/endo.143.2.8657","article-title":"Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1\u03b1-hydroxylase gene.","volume":"143","author":"Yoshida","year":"2002","journal-title":"Endocrinology"},{"key":"2020071614205734200_R19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071614205734200_R20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"2020071614205734200_R21","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia.","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/BF00731252","article-title":"Cloning and sequence homology of a rat UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase.","volume":"12","author":"Hagen","year":"1995","journal-title":"Glycoconj J"},{"key":"2020071614205734200_R23","doi-asserted-by":"crossref","first-page":"13843","DOI":"10.1074\/jbc.272.21.13843","article-title":"cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.","volume":"272","author":"Hagen","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071614205734200_R24","doi-asserted-by":"crossref","first-page":"25362","DOI":"10.1074\/jbc.274.36.25362","article-title":"Cloning and characterization of a close homologue of human UDP-N-acetyl-\u03b1-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.","volume":"274","author":"Bennett","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071614205734200_R25","doi-asserted-by":"crossref","first-page":"16845","DOI":"10.1016\/S0021-9258(19)89468-1","article-title":"Molecular cloning of a rat submandibular gland apomucin.","volume":"269","author":"Albone","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071614205734200_R26","first-page":"365","author":"Rozen","year":"2000"},{"key":"2020071614205734200_R27","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice.","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"2020071614205734200_R28","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-\u03b1-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.","volume":"91","author":"Garringer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R29","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.31947","article-title":"Two novel GALNT3 mutations in familial tumoral calcinosis.","volume":"143","author":"Garringer","year":"2007","journal-title":"Am J Med Genet A"},{"key":"2020071614205734200_R31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders.","volume":"83","author":"Frishberg","year":"2005","journal-title":"J Mol Med"},{"key":"2020071614205734200_R32","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2006-1825","article-title":"Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.","volume":"92","author":"Ichikawa","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614205734200_R33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2020071614205734200_R34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1152\/physiolgenomics.00210.2003","article-title":"The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia.","volume":"18","author":"Meyer","year":"2004","journal-title":"Physiol Genomics"},{"key":"2020071614205734200_R35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.05-5432fje","article-title":"Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process.","volume":"20","author":"Razzaque","year":"2006","journal-title":"FASEB J"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/6\/2543\/9003203\/endo2543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/6\/2543\/9003203\/endo2543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T18:12:10Z","timestamp":1633111930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/150\/6\/2543\/2456055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2008-0877","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}